Call Options Transactions Made in Q1 2023 in Arbutus Biopharma Corp (ABUS)
This table provides information about the institutional ownership of Arbutus Biopharma Corp (ABUS) during Q1 2023. The information is specifically focused on institutions that hold call options of Arbutus Biopharma Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2023
Q1 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
206K+ 152.34% |
$458K - $637K
|
340K
$1.34M
|
|
|
May 11, 2023
Q1 2023
|
Citigroup Inc
|
BUY
|
CALL |
184KNew |
$409K - $569K
|
184K
$723K
|
|
|
May 15, 2023
Q1 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
48.9K+ 48.37% |
$109K - $152K
|
150K
$591K
|
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-67.7K- 29.06% |
$151K - $210K
|
165K
$651K
|
|
|
May 12, 2023
Q1 2023
|
Peak6 Investments LLC
Chicago, IL |
SELL
|
CALL |
-310K- 41.76% |
$691K - $961K
|
432K
$1.7M
|